5XB-99829-31362
3 vaccinations
6 coded responses
36 check-ins
6 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 26-30
- ZIP prefix
- 377 / TN
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2020-12-29
Survey response — day 0, dose 1MedDRA: Pain in extremity — Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body achesFree text: Arm soreness, mild.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-30
Survey response — days 1–6 daily, dose 1MedDRA: Discomfort — Feeling: Good · Site: Pain · Muscle or body achesFree text: It's not pain, but soreness. Wish that was an option above.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-31
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-01
Survey response — days 1–6 daily, dose 1MedDRA: Pain in extremity — Feeling: Good · Site: Pain · Joint pains, Muscle or body achesFree text: Soreness at arm.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-02
- 2021-01-03
- 2021-01-05
-
2021-01-12
Survey response — day 14, dose 1MedDRA: Exposure to SARS-CoV-2, Malaise, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Came into contact with someone with COVID, may have contracted. First test 48hrs after exposure negative, waiting on second test now that was done 6 days after exposure but now with COVID symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-18
Dose 2 — Pfizer-BioNTech
-
2021-01-19
Survey response — days 1–6 daily, dose 2MedDRA: Pain — Feeling: Fair · Site: Pain, Swelling · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: SorenessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-01-23
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-04-19
- 2021-07-19
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-27
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-30
-
2022-04-04
Survey response — 6 months, dose 3MedDRA: Emergency care, Nasopharyngitis, Office visit, Prostatitis, SARS-CoV-2 test negative, Urinary tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Viral cold of some sort, Prostatitis and UTI possibly from a lot of sitting during that illness time down. Tested negative for all including COVID. Required to see primary care, walk-in clinic, and ER visit last week.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-04
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-04-06
- 2022-09-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-18 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
Call center
3 call center cases
1 unsuccessful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Arm soreness, mild.
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): It's not pain, but soreness. Wish that was an option above.
Systemic reaction (other): Soreness at arm.
Release 1 — day 14, dose 1
Symptoms: Came into contact with someone with COVID, may have contracted. First test 48hrs after exposure negative, waiting on second test now that was done 6 days after exposure but now with COVID symptoms.
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Soreness
Release 11 — 6 months, dose 3
Symptoms: Viral cold of some sort, Prostatitis and UTI possibly from a lot of sitting during that illness time down. Tested negative for all including COVID. Required to see primary care, walk-in clinic, and ER visit last week.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Emergency care | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | ✓ | ✓ | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Prostatitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Unevaluable event | ○ | ○ | ○ |
| SD | Urinary tract infection | · | · | ✓ |
| SRO | Discomfort | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release